EPO Patents = 3

Forward Citations = 1

Loading Chart...

7 inventors (with patents filed for the assignee):

Jesus E Villafranca (3 out of 3 patents)

Michael O'Neill (2 out of 4 patents)

William A Janz (2 out of 2 patents)

4. Hongqiao Wu (2 out of 5 patents)

5. Barbara Kidon (2 out of 4 patents)

6. Charles Richard Kissinger (2 out of 2 patents)

7. Guohong Li (1 out of 1 patent)

5 patents: Sort by Forward Citations

1. 12496281 - Compounds for prevention and treatment of hemorrhage and vasculature instability (2025-12-16),

2. 12357596 - Compounds for prevention and treatment of obesity and related disorders (2025-07-15),

3. 11938104 - Compositions and methods for prevention and treatment of coronavirus and related disorders (2024-03-26),

4. 11584711 - 2,2,2-trifluoroacetic acid 1-(2,4-dimethylphenyl)-2-[(3-methoxyphenyl)methylene] method of making the same (2023-02-21),

5. 10968167 - 2,2,2-trifluoroacetic acid 1-(2,4-Dimethylphenyl)-2-[(3-methoxyphenyl)methylene] hydrazide polymorphs and method of making the same (2021-04-06),

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

5 Patents

#875 in San Diego, CA

#12,073 in California

#51,644 in US

San Diego, CA, United States of America

Abrexa Pharmaceuticals, Inc.

Forward Citations = 1

7 inventors:

Jesus E Villafranca (3 out of 3 patents)

Michael O'Neill (2 out of 4 patents)

William A Janz (2 out of 2 patents)

4. Hongqiao Wu (2 out of 5 patents)

5. Barbara Kidon (2 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Abrexa Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/abrexa-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]